MediWound Ltd. (MDWD) saw a big move on Friday, as the company’s shares fell over 6% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for MDWD, as the stock is now down over 12% in the past one-month time frame.
The integrated biopharmaceutical company has seen a flat track record when it comes to current year estimate revisions over the past few weeks, and the consensus for earnings hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch of this firm in the near future, and especially on earnings estimates following the recent slump.
MDWD currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0%.
Some better-ranked stocks in the same sector include BioCryst Pharmaceuticals, Inc. (BCRX), Endo International plc (ENDP) and Esperion Therapeutics, Inc. (ESPR). All these stocks carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
MEDIWOUND LTD ORD (MDWD): Free Stock Analysis Report
BIOCRYST PHARMACEUTICALS INC (BCRX): Free Stock Analysis Report
ENDO INTERNATIONAL PLC ORD (ENDP): Free Stock Analysis Report
ESPERION THERAPEUTICS INC (ESPR): Free Stock Analysis Report
Zacks Investment Research
- Personal Investing Ideas & Strategies
- Finance Trading